Evotec

company

Investments

Number of Investments
Number of Lead Investments
23
5
Evotec has made 23 investments. Their most recent investment was on Dec 1, 2022, when Carrick Therapeutics, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Dec 1, 2022 Carrick Therapeutics Series C — Biotechnology —
Nov 29, 2022 Cajal Neuroscience Series A — Biotechnology —
May 3, 2022 Tubulis Series B — Biotechnology —
Feb 16, 2022 Centauri Therapeutics Series A — Biotechnology —
Feb 15, 2022 IMIDomics Corporate Round — Biotechnology Yes
Aug 18, 2021 Immunitas Therapeutics Series B — Biotechnology —
Jul 29, 2021 Topas Therapeutics Series B — Advanced Materials —
Apr 21, 2021 OxVax Seed — Biotechnology Yes
Mar 4, 2021 Exscientia Series C — Artificial Intelligence —
Mar 2, 2021 ARGOBIO Funding Round — Biotechnology —
Jan 8, 2021 Blacksmith Medicines Seed — Biotechnology —
Jun 24, 2020 Autobahn Labs Seed — Biotechnology Yes
May 26, 2020 Exscientia Series C — Artificial Intelligence —
Apr 16, 2020 leon nanodrugs Series B — Biotechnology —
Nov 22, 2019 Immunitas Therapeutics Series A — Biotechnology —
Jul 9, 2019 Breakpoint Therapeutics Series Unknown — Biotechnology —
Apr 1, 2019 Celmatix Series Unknown — Biotechnology —
Jan 7, 2019 Exscientia Series B — Artificial Intelligence —
Sep 28, 2017 Exscientia Series A — Artificial Intelligence Yes
Apr 25, 2017 Forge Therapeutics Series A — Biotechnology —
Jan 9, 2017 Eternygen Series A — Biotechnology —
Oct 3, 2016 Carrick Therapeutics Series A — Biotechnology —
Dec 2, 2014 Sanofi Post-IPO Equity — Health Care Yes